Genistein treatment of MCF-7-C3 and T47D breast cancer cells resulted in dysregulation of the human oncoprotein known as the carcinogenic inhibitor of protein phosphatase 2A (CIP2A), suggesting that CIP2A is a target of genistein responsible for inducing apoptosis and growth suppression [192]. The gene discussed is CIP2A; the disease is breast cancer.